Cytek Biosciences (CTKB) Share-based Compensation Growth (3y) (2023 - 2025)
Cytek Biosciences (CTKB) Share-based Compensation Growth (3y) (2023 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.32 Bn | 174.03 Bn | 6.27 Bn | 4.10% |
| 2 | Stryker | 128.59 Bn | 125.71 Bn | 3.81 Bn | 23.38% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 8.20% |
| 4 | Boston Scientific | 67.77 Bn | 66.32 Bn | 3.61 Bn | 14.70% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.46 Bn | 1.29 Bn | 5.29% |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.15 Bn | 1.98 Bn | 13.40% |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 0.56% |
| 8 | Smith & Nephew | 26.77 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.24 Bn | 22.11 Bn | 2.07 Bn | - |
| 10 | Cytek Biosciences | 580.46 Mn | 514.76 Mn | 21.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 34.91% |
| Sep 30, 2025 | 8.95% |
| Jun 30, 2025 | 19.95% |
| Mar 31, 2025 | 20.00% |
| Dec 31, 2024 | -28.95% |
| Sep 30, 2024 | -12.64% |
| Jun 30, 2024 | -118.67% |
| Mar 31, 2024 | 131.26% |
| Dec 31, 2023 | 333.31% |
| Sep 30, 2023 | -116.66% |
| Jun 30, 2023 | 278.75% |